Cancer News: Other

New drug brings hope to patients with rare cancers

New drug Afinitor® (everolimus) reduced the disease progression risk in patients with advanced, nonfunctional neuroendocrine tumors of gastrointestinal or lung origin.

More personalized treatment needed for metastatic cancer patients

A new study reveals that for metastatic cancer patients, an individualized approach would be beneficial to select the most appropriate and effective therapy.

Gastrointestinal tumors associated with higher cancer risk

Patients with gastrointestinal stromal tumors may develop additional malignancies before and after their diagnosis, according to the first population-based study.

Rare blood cancer targeted therapy gets EU approval

Ruxolitinib was approved in EU for the treatment of adult patients of a rare and incurable blood cancer associated with an overproduction of blood cells.

Chemotherapy added to radiation does not help vulvar cancer treatment

The addition of chemotherapy to post-surgical radiation treatment is not effective in treating vulvar cancer according to the latest research.

Targeted drugs may help in rare adrenal cancer

Adrenocortical carcinoma, a rare and dangerous endocrine malignancy with no effective drug treatments, may respond to targeted therapies, early studies suggest.

Inaccurate rare cancer diagnosis remains a major obstacle for treatment

An accurate cancer diagnosis is particularly important for rare cancers, which present additional challenges, and inaccurate diagnoses present major obstacles.

Potential vaccine against ovarian cancer, pancreatic cancer & mesothelioma

Scientists are building proteins that act on the tumor cell surface, and increase immune function against some tumors. Their work is still in laboratory phase.

A less invasive technique for vulvar cancer

New research showed that a less invasive technique for vulvar cancer reduced complications while maintaining a low rate of future occurrence.